share_log

Ginkgo Bioworks Raises FY24 Revenue From $170M-$190M To $215M-$235M Vs $185.52M Est.

Ginkgo Bioworksは、売上高をFY24年について、$170 millionから$190 millionから$215 millionから$235 millionに引き上げ、$185.52 millionの見積もりに対しています。

Benzinga ·  2024/11/12 17:05

Full Year 2024 Outlook

  • Ginkgo previously issued 2024 guidance for Total revenue of $170-190 million; Cell Engineering services revenue of $120-140 million; and Biosecurity revenue of at least $50 million. Ginkgo updates its previously issued guidance solely to reflect the impact of the previously mentioned $45 million non-cash deferred revenue release in the third quarter to:
    • Total revenue guidance of $215-235 million in 2024;
    • Cell Engineering services revenue of $165-185 million in 2024; and
    • Biosecurity revenue of at least $50 million in 2024.
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする